US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

InMed Pharmaceuticals Inc

0.8770

-0.0131-1.47%

Post-market: 0.92000.0430+4.90%17:58 EST

Volume:52.01K

Turnover:45.72K

Market Cap:2.56M

PE:-0.30

High:0.9600

Open:0.8883

Low:0.8650

Close:0.8901

52wk High:7.98

52wk Low:0.8650

Shares:2.92M

Float Shares:1.48M

Volume Ratio:0.73

T/O Rate:3.50%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8800

EPS(LYR):-8.3630

ROE:-97.20%

ROA:-49.77%

PB:0.27

PE(LYR):-0.10

Loading ...

Overview Company News Filings

InMed Pharmaceuticals Inc. Q2 BayMedica revenue drops 26% to USD 0.8 million

InMed Pharma Q4 R&D expenses USD 0.63 million, down 30%

InMed Pharmaceuticals Inc. Held Annual Shareholder Meeting

ADVISORY-Dated alerts on InMed Pharmaceuticals withdrawn

InMed Pharmaceuticals Inc - Expects Negative Impact on Baymedica From New Act H.r. 5371 - SEC Filing

THOMSON REUTERS

BayMedica Faces Uncertainty as New Law Threatens Commercial Operations

Why Did Vivakor Shares Surge 17% After Hours?

Benzinga_recent_news

What's Driving InMed's (INM) 22% After-Hours Surge?

InMed Pharmaceuticals Completes Key Study for INM-901

InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901

InMed Pharmaceuticals Completes Large Animal Study for Alzheimer's Drug Candidate INM-901

InMed Pharmaceuticals reports $1.1 million in BayMedica revenues for Q1 fiscal 2026

InMed Pharmaceuticals Inc. Announces Date for Upcoming Shareholder Meeting

InMed Pharmaceuticals Files Amendment to Annual Report

InMed Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director John Steven Bathery

InMed Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director Neil Klompas

InMed Pharmaceuticals Appoints John Bathery to Board of Directors; Bryan Baldasare to Step Down

InMed Pharmaceuticals Appoints Neil Klompas to Board of Directors

InMed Pharmaceuticals Reports Fiscal 2025 Results: Sales Increase 8% to $4.9M, Net Loss Widens to $8.2M

InMed Pharmaceuticals FY Net Income USD -8.2 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/INM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INM\",,,,,undefined,":{"symbol":"INM","market":"US","secType":"STK","nameCN":"InMed Pharmaceuticals Inc","latestPrice":0.877,"timestamp":1771016400000,"preClose":0.8901,"halted":0,"volume":52010,"hourTrading":{"tag":"盘后","latestPrice":0.92,"preClose":0.877,"latestTime":"17:58 EST","volume":447,"amount":398.1739,"timestamp":1771023523711,"change":0.043,"changeRate":0.049031,"amplitude":0.051311},"delay":0,"changeRate":-0.014717447477811483,"floatShares":1484000,"shares":2919186,"eps":-2.88,"marketStatus":"Market Closed","change":-0.0131,"latestTime":"02-13 16:00:00 EST","open":0.8883,"high":0.96,"low":0.865,"amount":45716.99804,"amplitude":0.10673,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.88,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.8901,"preHourTrading":{"tag":"盘前","latestPrice":0.89,"preClose":0.8901,"latestTime":"08:00 EST","volume":1644,"amount":1414.587198,"timestamp":1770987603520,"change":-0.0001,"changeRate":-0.000112,"amplitude":0.032581},"postHourTrading":{"tag":"盘后","latestPrice":0.92,"preClose":0.877,"latestTime":"17:58 EST","volume":447,"amount":398.1739,"timestamp":1771023523711,"change":0.043,"changeRate":0.049031,"amplitude":0.051311},"volumeRatio":0.7298857357321407},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INM\",,,,,undefined,":{"symbol":"INM","floatShares":1484000,"roa":"-49.77%","roe":"-97.20%","lyrEps":-8.362969,"volumeRatio":0.7298857357321407,"shares":2919186,"dividePrice":0,"high":0.96,"amplitude":0.10673,"preClose":0.8901,"low":0.865,"week52Low":0.865,"pbRate":"0.27","psRate":"0.57","week52High":7.98,"institutionHeld":0.0434,"latestPrice":0.877,"eps":-2.88,"divideRate":0,"volume":52010,"delay":0,"ttmEps":-2.88,"open":0.8883,"prevYearClose":1.06,"prevWeekClose":0.9403,"prevMonthClose":1.1,"prevQuarterClose":1.06,"fiveDayClose":0.9403,"twentyDayClose":1.07,"sixtyDayClose":1.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-11","symbol":"INM","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":-3.64},{"market":"US","date":"2025-09-23","symbol":"INM","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1758600000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-05-12","symbol":"INM","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-1.94},{"market":"US","date":"2025-02-12","symbol":"INM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"post","actualEps":-3.64},{"market":"US","date":"2024-11-14","symbol":"INM","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-2.71}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INM","date":"2026-02-13","current":-0.304514,"percent":0.465419,"low":-5.562073,"twenty":-1.419122,"median":-0.436715,"eighty":-0.259826,"high":-0.109662,"avg":-0.92353,"sd":1.111435,"marketCap":3622305},"quantilePoints":[{"date":"2021-02-19","current":-4.701404,"twenty":-17.824585,"median":-4.873047,"eighty":-2.912098,"marketCap":35181559},{"date":"2021-02-26","current":-4.540028,"twenty":-17.718846,"median":-4.881659,"eighty":-2.915058,"marketCap":33973954},{"date":"2021-03-05","current":-4.518512,"twenty":-17.659627,"median":-4.873047,"eighty":-2.93001,"marketCap":33812940},{"date":"2021-03-12","current":-5.110222,"twenty":-17.608697,"median":-4.867099,"eighty":-2.940269,"marketCap":38240825},{"date":"2021-03-19","current":-4.410928,"twenty":-17.553486,"median":-4.848301,"eighty":-2.946507,"marketCap":33007870},{"date":"2021-03-26","current":-3.722393,"twenty":-17.52,"median":-4.826923,"eighty":-2.950432,"marketCap":27855422},{"date":"2021-04-01","current":-3.668601,"twenty":-17.473095,"median":-4.811262,"eighty":-2.951661,"marketCap":27452887},{"date":"2021-04-09","current":-3.905285,"twenty":-17.400588,"median":-4.800485,"eighty":-2.961139,"marketCap":29224041},{"date":"2021-04-16","current":-3.21675,"twenty":-17.347775,"median":-4.766548,"eighty":-2.974234,"marketCap":24071593},{"date":"2021-04-23","current":-3.08765,"twenty":-17.216313,"median":-4.744437,"eighty":-2.974234,"marketCap":23105509},{"date":"2021-04-30","current":-4.023627,"twenty":-17.026588,"median":-4.709589,"eighty":-2.978045,"marketCap":30109618},{"date":"2021-05-07","current":-3.711635,"twenty":-16.952002,"median":-4.701404,"eighty":-2.987766,"marketCap":27774915},{"date":"2021-05-14","current":-2.595598,"twenty":-16.924823,"median":-4.638346,"eighty":-2.978045,"marketCap":22219932},{"date":"2021-05-21","current":-2.57679,"twenty":-16.886827,"median":-4.582492,"eighty":-2.950432,"marketCap":22058918},{"date":"2021-05-28","current":-2.774281,"twenty":-16.839977,"median":-4.561545,"eighty":-2.925144,"marketCap":23749565},{"date":"2021-06-04","current":-2.689642,"twenty":-16.730845,"median":-4.530635,"eighty":-2.909667,"marketCap":23025002},{"date":"2021-06-11","current":-2.670833,"twenty":-16.332407,"median":-4.507753,"eighty":-2.88174,"marketCap":22863988},{"date":"2021-06-18","current":-2.586194,"twenty":-16.270406,"median":-4.469611,"eighty":-2.878045,"marketCap":22139425},{"date":"2021-06-25","current":-2.689642,"twenty":-16.177294,"median":-4.459208,"eighty":-2.850478,"marketCap":23025002},{"date":"2021-07-02","current":-4.504067,"twenty":-16.123723,"median":-4.440378,"eighty":-2.850478,"marketCap":38557609},{"date":"2021-07-09","current":-4.136965,"twenty":-16.117671,"median":-4.430085,"eighty":-2.852193,"marketCap":35414983},{"date":"2021-07-16","current":-3.755743,"twenty":-16.10351,"median":-4.412515,"eighty":-2.859458,"marketCap":32151486},{"date":"2021-07-23","current":-3.529833,"twenty":-16.067812,"median":-4.347297,"eighty":-2.864803,"marketCap":30217562},{"date":"2021-07-30","current":-3.939294,"twenty":-16.064037,"median":-4.338811,"eighty":-2.877729,"marketCap":33722799},{"date":"2021-08-06","current":-3.529833,"twenty":-16.064016,"median":-4.330554,"eighty":-2.879311,"marketCap":30217562},{"date":"2021-08-13","current":-3.38864,"twenty":-16.035558,"median":-4.302672,"eighty":-2.880392,"marketCap":29008860},{"date":"2021-08-20","current":-2.936821,"twenty":-15.94457,"median":-4.279979,"eighty":-2.880392,"marketCap":25141012},{"date":"2021-08-27","current":-3.445117,"twenty":-15.927658,"median":-4.262646,"eighty":-2.880392,"marketCap":29492341},{"date":"2021-09-03","current":-3.247447,"twenty":-15.820352,"median":-4.257264,"eighty":-2.880392,"marketCap":27800157},{"date":"2021-09-10","current":-2.950941,"twenty":-15.788289,"median":-4.216197,"eighty":-2.885785,"marketCap":25261882},{"date":"2021-09-17","current":-2.809747,"twenty":-15.733159,"median":-4.179323,"eighty":-2.885785,"marketCap":24053179},{"date":"2021-09-24","current":-2.156051,"twenty":-15.70031,"median":-4.162564,"eighty":-2.880137,"marketCap":21998385},{"date":"2021-10-01","current":-2.013894,"twenty":-15.678345,"median":-4.122845,"eighty":-2.858005,"marketCap":20547942},{"date":"2021-10-08","current":-1.788812,"twenty":-15.635528,"median":-4.061281,"eighty":-2.843621,"marketCap":18251407},{"date":"2021-10-15","current":-1.939789,"twenty":-15.604677,"median":-4.046763,"eighty":-2.819107,"marketCap":19791835},{"date":"2021-10-22","current":-2.244612,"twenty":-15.554466,"median":-4.023818,"eighty":-2.810231,"marketCap":22901980},{"date":"2021-10-29","current":-2.112984,"twenty":-15.542127,"median":-4.012869,"eighty":-2.777692,"marketCap":21558963},{"date":"2021-11-05","current":-2.036778,"twenty":-15.531935,"median":-4.010426,"eighty":-2.769876,"marketCap":20781426},{"date":"2021-11-12","current":-1.709785,"twenty":-15.527551,"median":-3.997897,"eighty":-2.754191,"marketCap":19791835},{"date":"2021-11-19","current":-2.222721,"twenty":-15.228473,"median":-3.989578,"eighty":-2.731557,"marketCap":25729385},{"date":"2021-11-26","current":-2.051743,"twenty":-15.126614,"median":-3.977217,"eighty":-2.725914,"marketCap":23750202},{"date":"2021-12-03","current":-1.795275,"twenty":-14.957789,"median":-3.95989,"eighty":-2.715078,"marketCap":20781426},{"date":"2021-12-10","current":-1.831913,"twenty":-14.769107,"median":-3.958784,"eighty":-2.689642,"marketCap":21205537},{"date":"2021-12-17","current":-1.776956,"twenty":-14.707731,"median":-3.947621,"eighty":-2.680238,"marketCap":20569371},{"date":"2021-12-23","current":-1.831913,"twenty":-14.696775,"median":-3.939294,"eighty":-2.667108,"marketCap":21205537},{"date":"2021-12-31","current":-1.599871,"twenty":-14.483821,"median":-3.932275,"eighty":-2.64262,"marketCap":18519502},{"date":"2022-01-07","current":-1.563232,"twenty":-14.125691,"median":-3.916962,"eighty":-2.622375,"marketCap":18095392},{"date":"2022-01-14","current":-1.514381,"twenty":-13.994724,"median":-3.910051,"eighty":-2.605474,"marketCap":17529911},{"date":"2022-01-21","current":-1.502169,"twenty":-13.862243,"median":-3.905779,"eighty":-2.598662,"marketCap":17388540},{"date":"2022-01-28","current":-1.306765,"twenty":-13.530227,"median":-3.896936,"eighty":-2.588264,"marketCap":15126616},{"date":"2022-02-04","current":-1.416679,"twenty":-13.286739,"median":-3.872197,"eighty":-2.5782,"marketCap":16398949},{"date":"2022-02-11","current":-1.441105,"twenty":-13.1169,"median":-3.859314,"eighty":-2.567718,"marketCap":16681689},{"date":"2022-02-18","current":-1.090286,"twenty":-12.972341,"median":-3.850987,"eighty":-2.541897,"marketCap":14843876},{"date":"2022-02-25","current":-1.048752,"twenty":-12.921635,"median":-3.835218,"eighty":-2.510959,"marketCap":14278395},{"date":"2022-03-04","current":-0.913763,"twenty":-12.78875,"median":-3.826339,"eighty":-2.456557,"marketCap":12440567},{"date":"2022-03-11","current":-0.77348,"twenty":-12.620122,"median":-3.819223,"eighty":-2.430338,"marketCap":10530669},{"date":"2022-03-18","current":-0.830694,"twenty":-12.524179,"median":-3.817701,"eighty":-2.381487,"marketCap":11309620},{"date":"2022-03-25","current":-1.162972,"twenty":-12.448941,"median":-3.813826,"eighty":-2.366975,"marketCap":15833468},{"date":"2022-04-01","current":-0.961113,"twenty":-12.421314,"median":-3.80846,"eighty":-2.320423,"marketCap":13085230},{"date":"2022-04-08","current":-0.923041,"twenty":-12.340632,"median":-3.799666,"eighty":-2.290621,"marketCap":12566881},{"date":"2022-04-14","current":-0.920825,"twenty":-12.172547,"median":-3.793184,"eighty":-2.258326,"marketCap":12536720},{"date":"2022-04-22","current":-0.949519,"twenty":-12.087364,"median":-3.788183,"eighty":-2.254589,"marketCap":12927371},{"date":"2022-04-29","current":-0.959962,"twenty":-11.743544,"median":-3.78444,"eighty":-2.233721,"marketCap":13069556},{"date":"2022-05-06","current":-0.991504,"twenty":-11.583497,"median":-3.769862,"eighty":-2.218543,"marketCap":13498984},{"date":"2022-05-13","current":-0.868731,"twenty":-11.561264,"median":-3.7507,"eighty":-2.204799,"marketCap":12152548},{"date":"2022-05-20","current":-0.808443,"twenty":-11.529634,"median":-3.743687,"eighty":-2.19116,"marketCap":11309191},{"date":"2022-05-27","current":-0.836294,"twenty":-11.40614,"median":-3.739194,"eighty":-2.173612,"marketCap":11698790},{"date":"2022-06-03","current":-0.711941,"twenty":-11.136562,"median":-3.728497,"eighty":-2.167357,"marketCap":9959233},{"date":"2022-06-10","current":-0.948505,"twenty":-10.968844,"median":-3.712344,"eighty":-2.157032,"marketCap":13268493},{"date":"2022-06-17","current":-0.778579,"twenty":-10.942532,"median":-3.703585,"eighty":-2.154308,"marketCap":10891418},{"date":"2022-06-24","current":-0.717787,"twenty":-10.880292,"median":-3.683165,"eighty":-2.146149,"marketCap":10041006},{"date":"2022-07-01","current":-0.688489,"twenty":-10.755269,"median":-3.668341,"eighty":-2.131087,"marketCap":9631169},{"date":"2022-07-08","current":-0.710461,"twenty":-10.643726,"median":-3.659586,"eighty":-2.120249,"marketCap":9938526},{"date":"2022-07-15","current":-0.542002,"twenty":-10.479006,"median":-3.64821,"eighty":-2.108968,"marketCap":7581984},{"date":"2022-07-22","current":-0.558116,"twenty":-10.294839,"median":-3.637153,"eighty":-2.104359,"marketCap":7807394},{"date":"2022-07-29","current":-0.571299,"twenty":-10.114867,"median":-3.635402,"eighty":-2.096403,"marketCap":7991821},{"date":"2022-08-05","current":-0.605284,"twenty":-9.946634,"median":-3.628996,"eighty":-2.091451,"marketCap":8467232},{"date":"2022-08-12","current":-0.573057,"twenty":-9.891359,"median":-3.618436,"eighty":-2.085559,"marketCap":8016411},{"date":"2022-08-19","current":-0.548008,"twenty":-9.876331,"median":-3.61316,"eighty":-2.078408,"marketCap":7666001},{"date":"2022-08-26","current":-0.381013,"twenty":-9.852411,"median":-3.600068,"eighty":-2.064697,"marketCap":5329930},{"date":"2022-09-02","current":-0.469198,"twenty":-9.829123,"median":-3.589546,"eighty":-2.047017,"marketCap":6563539},{"date":"2022-09-09","current":-0.645715,"twenty":-9.811879,"median":-3.583988,"eighty":-2.038956,"marketCap":9032807},{"date":"2022-09-16","current":-0.437339,"twenty":-9.79624,"median":-3.579093,"eighty":-2.027156,"marketCap":6117868},{"date":"2022-09-23","current":-0.272138,"twenty":-9.75563,"median":-3.558512,"eighty":-1.98569,"marketCap":5061798},{"date":"2022-09-30","current":-0.322154,"twenty":-9.748781,"median":-3.550453,"eighty":-1.978355,"marketCap":5992097},{"date":"2022-10-07","current":-0.377671,"twenty":-9.744902,"median":-3.550259,"eighty":-1.968169,"marketCap":7024722},{"date":"2022-10-14","current":-0.259435,"twenty":-9.701607,"median":-3.543953,"eighty":-1.939789,"marketCap":4825520},{"date":"2022-10-21","current":-0.23012,"twenty":-9.660906,"median":-3.529833,"eighty":-1.938968,"marketCap":4280264},{"date":"2022-10-28","current":-0.165695,"twenty":-9.660557,"median":-3.529406,"eighty":-1.927287,"marketCap":3081943},{"date":"2022-11-04","current":-0.125908,"twenty":-9.651217,"median":-3.518976,"eighty":-1.885944,"marketCap":2341902},{"date":"2022-11-11","current":-0.146838,"twenty":-9.633739,"median":-3.515678,"eighty":-1.831913,"marketCap":2810283},{"date":"2022-11-18","current":-0.135091,"twenty":-9.631614,"median":-3.50736,"eighty":-1.807487,"marketCap":2585460},{"date":"2022-11-25","current":-0.139496,"twenty":-9.62978,"median":-3.500639,"eighty":-1.793982,"marketCap":2669768},{"date":"2022-12-02","current":-0.134112,"twenty":-9.61218,"median":-3.485981,"eighty":-1.774589,"marketCap":2566725},{"date":"2022-12-09","current":-0.168646,"twenty":-9.584525,"median":-3.474308,"eighty":-1.73754,"marketCap":3227673},{"date":"2022-12-16","current":-0.147877,"twenty":-9.57858,"median":-3.458773,"eighty":-1.7049,"marketCap":2830176},{"date":"2022-12-23","current":-0.109662,"twenty":-9.577146,"median":-3.453884,"eighty":-1.646279,"marketCap":2098782},{"date":"2022-12-30","current":-0.167816,"twenty":-9.569977,"median":-3.445117,"eighty":-1.636509,"marketCap":3211773},{"date":"2023-01-06","current":-0.136246,"twenty":-9.503442,"median":-3.424131,"eighty":-1.594986,"marketCap":2607578},{"date":"2023-01-13","current":-0.157016,"twenty":-9.347753,"median":-3.389483,"eighty":-1.553462,"marketCap":3005075},{"date":"2023-01-20","current":-0.176123,"twenty":-9.305586,"median":-3.367367,"eighty":-1.497284,"marketCap":3370772},{"date":"2023-01-27","current":-0.149539,"twenty":-9.244187,"median":-3.318043,"eighty":-1.444769,"marketCap":2861976},{"date":"2023-02-03","current":-0.18277,"twenty":-9.126214,"median":-3.237178,"eighty":-1.424007,"marketCap":3497971},{"date":"2023-02-10","current":-0.158677,"twenty":-9.049621,"median":-3.21675,"eighty":-1.32142,"marketCap":3036875},{"date":"2023-02-17","current":-0.314037,"twenty":-8.960676,"median":-3.208475,"eighty":-1.175433,"marketCap":5325113},{"date":"2023-02-24","current":-0.261043,"twenty":-8.799709,"median":-3.190969,"eighty":-1.096361,"marketCap":4426500},{"date":"2023-03-03","current":-0.219826,"twenty":-8.626648,"median":-3.162889,"eighty":-1.054982,"marketCap":3727579},{"date":"2023-03-10","current":-0.206087,"twenty":-8.424258,"median":-3.150575,"eighty":-1.031484,"marketCap":3494605},{"date":"2023-03-17","current":-0.207068,"twenty":-8.183975,"median":-3.130683,"eighty":-0.994181,"marketCap":3511246},{"date":"2023-03-24","current":-0.257118,"twenty":-7.984545,"median":-3.120373,"eighty":-0.97359,"marketCap":4359936},{"date":"2023-03-31","current":-0.211975,"twenty":-7.663458,"median":-3.104393,"eighty":-0.958647,"marketCap":3594451},{"date":"2023-04-06","current":-0.219826,"twenty":-7.591537,"median":-3.095186,"eighty":-0.938231,"marketCap":3727579},{"date":"2023-04-14","current":-0.239453,"twenty":-7.372167,"median":-3.080087,"eighty":-0.91501,"marketCap":4060399},{"date":"2023-04-21","current":-0.257118,"twenty":-7.283691,"median":-3.075515,"eighty":-0.88685,"marketCap":4359936},{"date":"2023-04-28","current":-0.239453,"twenty":-7.053617,"median":-3.055491,"eighty":-0.863776,"marketCap":4060399},{"date":"2023-05-05","current":-0.247304,"twenty":-6.608202,"median":-3.013057,"eighty":-0.83964,"marketCap":4193526},{"date":"2023-05-12","current":-0.229639,"twenty":-6.272615,"median":-2.999316,"eighty":-0.829864,"marketCap":3893989},{"date":"2023-05-19","current":-0.298864,"twenty":-6.136321,"median":-2.972592,"eighty":-0.81381,"marketCap":4626192},{"date":"2023-05-26","current":-0.275212,"twenty":-5.802648,"median":-2.950432,"eighty":-0.795527,"marketCap":4260084},{"date":"2023-06-02","current":-0.283813,"twenty":-5.610115,"median":-2.936821,"eighty":-0.789845,"marketCap":4393212},{"date":"2023-06-09","current":-0.294563,"twenty":-5.501833,"median":-2.908583,"eighty":-0.775671,"marketCap":4559621},{"date":"2023-06-16","current":-0.273062,"twenty":-5.314445,"median":-2.894463,"eighty":-0.742264,"marketCap":4226802},{"date":"2023-06-23","current":-0.21931,"twenty":-5.222303,"median":-2.880392,"eighty":-0.721249,"marketCap":3394754},{"date":"2023-06-30","current":-0.199959,"twenty":-5.157852,"median":-2.877729,"eighty":-0.71764,"marketCap":3095214},{"date":"2023-07-07","current":-0.202044,"twenty":-5.13999,"median":-2.850049,"eighty":-0.710758,"marketCap":3127497},{"date":"2023-07-14","current":-0.21501,"twenty":-5.101933,"median":-2.828796,"eighty":-0.670911,"marketCap":3328191},{"date":"2023-07-21","current":-0.212881,"twenty":-5.034597,"median":-2.810352,"eighty":-0.619284,"marketCap":3295241},{"date":"2023-07-28","current":-0.240811,"twenty":-4.980986,"median":-2.775332,"eighty":-0.588585,"marketCap":3727573},{"date":"2023-08-04","current":-0.213526,"twenty":-4.89877,"median":-2.764016,"eighty":-0.578653,"marketCap":3305226},{"date":"2023-08-11","current":-0.208538,"twenty":-4.840534,"median":-2.736664,"eighty":-0.570831,"marketCap":3228012},{"date":"2023-08-18","current":-0.189209,"twenty":-4.800539,"median":-2.722802,"eighty":-0.556916,"marketCap":2928808},{"date":"2023-08-25","current":-0.176308,"twenty":-4.757869,"median":-2.699046,"eighty":-0.543057,"marketCap":2729116},{"date":"2023-09-01","current":-0.176523,"twenty":-4.701404,"median":-2.684528,"eighty":-0.519267,"marketCap":2732444},{"date":"2023-09-08","current":-0.174179,"twenty":-4.614511,"median":-2.670833,"eighty":-0.45244,"marketCap":2696167},{"date":"2023-09-15","current":-0.187381,"twenty":-4.548635,"median":-2.64262,"eighty":-0.384697,"marketCap":2900518},{"date":"2023-09-22","current":-0.168783,"twenty":-4.500751,"median":-2.617742,"eighty":-0.365862,"marketCap":2612629},{"date":"2023-09-29","current":-0.148357,"twenty":-4.456855,"median":-2.601482,"eighty":-0.349225,"marketCap":2296451},{"date":"2023-10-06","current":-0.283923,"twenty":-4.419852,"median":-2.587485,"eighty":-0.319664,"marketCap":2256513},{"date":"2023-10-13","current":-0.267172,"twenty":-4.341742,"median":-2.57679,"eighty":-0.298637,"marketCap":2123385},{"date":"2023-10-20","current":-0.251259,"twenty":-4.314698,"median":-2.545917,"eighty":-0.294563,"marketCap":1996914},{"date":"2023-10-27","current":-0.284091,"twenty":-4.26946,"median":-2.518335,"eighty":-0.290616,"marketCap":2257844},{"date":"2023-11-03","current":-0.198202,"twenty":-4.234418,"median":-2.458342,"eighty":-0.287491,"marketCap":1575232},{"date":"2023-11-10","current":-0.31478,"twenty":-4.171611,"median":-2.424984,"eighty":-0.284498,"marketCap":2501750},{"date":"2023-11-17","current":-0.377169,"twenty":-4.073147,"median":-2.375815,"eighty":-0.284498,"marketCap":2630468},{"date":"2023-11-24","current":-0.29009,"twenty":-4.042182,"median":-2.333757,"eighty":-0.284498,"marketCap":2023163},{"date":"2023-12-01","current":-0.331532,"twenty":-4.011928,"median":-2.296893,"eighty":-0.284248,"marketCap":2312186},{"date":"2023-12-08","current":-0.288583,"twenty":-3.998922,"median":-2.258468,"eighty":-0.2843,"marketCap":2012653},{"date":"2023-12-15","current":-0.256636,"twenty":-3.976452,"median":-2.253933,"eighty":-0.283813,"marketCap":1789842},{"date":"2023-12-22","current":-0.261006,"twenty":-3.95862,"median":-2.221514,"eighty":-0.279513,"marketCap":1820321},{"date":"2023-12-29","current":-0.292313,"twenty":-3.939655,"median":-2.21694,"eighty":-0.279513,"marketCap":2038665},{"date":"2024-01-05","current":-0.283309,"twenty":-3.930495,"median":-2.205104,"eighty":-0.279513,"marketCap":1975868},{"date":"2024-01-12","current":-0.265451,"twenty":-3.909047,"median":-2.183725,"eighty":-0.278713,"marketCap":1851325},{"date":"2024-01-19","current":-0.267486,"twenty":-3.893486,"median":-2.170704,"eighty":-0.276896,"marketCap":1865514},{"date":"2024-01-26","current":-0.272233,"twenty":-3.859314,"median":-2.161479,"eighty":-0.275212,"marketCap":1898620},{"date":"2024-02-02","current":-0.273514,"twenty":-3.829977,"median":-2.155058,"eighty":-0.273062,"marketCap":1907554},{"date":"2024-02-09","current":-0.246162,"twenty":-3.819218,"median":-2.137913,"eighty":-0.272198,"marketCap":1716798},{"date":"2024-02-16","current":-0.330917,"twenty":-3.811477,"median":-2.121597,"eighty":-0.272052,"marketCap":2101768},{"date":"2024-02-23","current":-0.385656,"twenty":-3.799666,"median":-2.111495,"eighty":-0.272052,"marketCap":2449438},{"date":"2024-03-01","current":-0.395765,"twenty":-3.790365,"median":-2.104996,"eighty":-0.272069,"marketCap":2513642},{"date":"2024-03-08","current":-0.361434,"twenty":-3.77492,"median":-2.09427,"eighty":-0.272069,"marketCap":2295591},{"date":"2024-03-15","current":-0.338546,"twenty":-3.743865,"median":-2.090885,"eighty":-0.272069,"marketCap":2150224},{"date":"2024-03-22","current":-0.35122,"twenty":-3.732159,"median":-2.078897,"eighty":-0.272069,"marketCap":2230721},{"date":"2024-03-28","current":-0.330726,"twenty":-3.711635,"median":-2.067667,"eighty":-0.272069,"marketCap":2100557},{"date":"2024-04-05","current":-0.324146,"twenty":-3.668341,"median":-2.046288,"eighty":-0.272052,"marketCap":2058764},{"date":"2024-04-12","current":-0.319473,"twenty":-3.645588,"median":-2.036778,"eighty":-0.272052,"marketCap":2029084},{"date":"2024-04-19","current":-0.287049,"twenty":-3.634478,"median":-1.990679,"eighty":-0.272052,"marketCap":1823147},{"date":"2024-04-26","current":-0.24032,"twenty":-3.619013,"median":-1.979132,"eighty":-0.271193,"marketCap":1526356},{"date":"2024-05-03","current":-0.251668,"twenty":-3.603314,"median":-1.962329,"eighty":-0.268812,"marketCap":1598434},{"date":"2024-05-10","current":-0.261586,"twenty":-3.583779,"median":-1.939767,"eighty":-0.265746,"marketCap":1661426},{"date":"2024-05-17","current":-0.283894,"twenty":-3.558424,"median":-1.934588,"eighty":-0.26466,"marketCap":1725018},{"date":"2024-05-24","current":-0.313999,"twenty":-3.549361,"median":-1.892015,"eighty":-0.26466,"marketCap":1907945},{"date":"2024-05-31","current":-0.31431,"twenty":-3.531479,"median":-1.831913,"eighty":-0.26466,"marketCap":1909835},{"date":"2024-06-07","current":-0.349241,"twenty":-3.52584,"median":-1.807487,"eighty":-0.26466,"marketCap":2122085},{"date":"2024-06-14","current":-0.326683,"twenty":-3.508176,"median":-1.788812,"eighty":-0.264462,"marketCap":1985014},{"date":"2024-06-21","current":-0.327371,"twenty":-3.487948,"median":-1.75253,"eighty":-0.264459,"marketCap":1989193},{"date":"2024-06-28","current":-0.364509,"twenty":-3.459237,"median":-1.721998,"eighty":-0.26445,"marketCap":2214858},{"date":"2024-07-05","current":-0.348691,"twenty":-3.453794,"median":-1.660934,"eighty":-0.26445,"marketCap":2118741},{"date":"2024-07-12","current":-0.40659,"twenty":-3.431567,"median":-1.636509,"eighty":-0.26445,"marketCap":2470550},{"date":"2024-07-15","current":-0.388976,"twenty":-3.42243,"median":-1.636509,"eighty":-0.26445,"marketCap":2363523},{"date":"2024-08-02","current":-0.262595,"twenty":-3.324863,"median":-1.563232,"eighty":-0.263006,"marketCap":1595601},{"date":"2024-08-09","current":-0.206964,"twenty":-3.271304,"median":-1.496063,"eighty":-0.261247,"marketCap":1257572},{"date":"2024-08-16","current":-0.211368,"twenty":-3.226426,"median":-1.444158,"eighty":-0.260742,"marketCap":1284329},{"date":"2024-08-23","current":-0.604014,"twenty":-3.214048,"median":-1.422786,"eighty":-0.25994,"marketCap":3670150},{"date":"2024-08-30","current":-0.506109,"twenty":-3.198903,"median":-1.318977,"eighty":-0.25994,"marketCap":3075256},{"date":"2024-09-06","current":-0.402481,"twenty":-3.17071,"median":-1.194123,"eighty":-0.25994,"marketCap":2445586},{"date":"2024-09-13","current":-0.411874,"twenty":-3.155604,"median":-1.095349,"eighty":-0.25994,"marketCap":2502659},{"date":"2024-09-20","current":-0.400865,"twenty":-3.140766,"median":-1.053943,"eighty":-0.25994,"marketCap":2435766},{"date":"2024-09-27","current":-0.340831,"twenty":-3.123332,"median":-1.030904,"eighty":-0.25994,"marketCap":2070981},{"date":"2024-10-04","current":-0.378367,"twenty":-3.107653,"median":-0.993734,"eighty":-0.25994,"marketCap":2904171},{"date":"2024-10-11","current":-0.364984,"twenty":-3.097872,"median":-0.972461,"eighty":-0.25994,"marketCap":2801451},{"date":"2024-10-18","current":-0.431028,"twenty":-3.084442,"median":-0.957163,"eighty":-0.25994,"marketCap":3308380},{"date":"2024-10-25","current":-0.534498,"twenty":-3.076161,"median":-0.921933,"eighty":-0.25994,"marketCap":4102567},{"date":"2024-10-31","current":-0.509569,"twenty":-3.0649,"median":-0.914802,"eighty":-0.25994,"marketCap":3911219},{"date":"2024-11-08","current":-0.409186,"twenty":-3.028503,"median":-0.877785,"eighty":-0.259935,"marketCap":3140726},{"date":"2024-11-15","current":-0.441893,"twenty":-3.002105,"median":-0.862067,"eighty":-0.259935,"marketCap":3391768},{"date":"2024-11-22","current":-0.455458,"twenty":-2.978718,"median":-0.837331,"eighty":-0.259935,"marketCap":3104670},{"date":"2024-11-29","current":-0.451891,"twenty":-2.952479,"median":-0.830694,"eighty":-0.259935,"marketCap":3080357},{"date":"2024-12-06","current":-0.570921,"twenty":-2.940269,"median":-0.816398,"eighty":-0.259935,"marketCap":3891733},{"date":"2024-12-13","current":-0.54248,"twenty":-2.915019,"median":-0.795569,"eighty":-0.259935,"marketCap":3697864},{"date":"2024-12-20","current":-0.436091,"twenty":-2.898418,"median":-0.78916,"eighty":-0.259935,"marketCap":2972652},{"date":"2024-12-27","current":-0.483492,"twenty":-2.891531,"median":-0.777131,"eighty":-0.259935,"marketCap":3295766},{"date":"2025-01-03","current":-0.505612,"twenty":-2.880392,"median":-0.752817,"eighty":-0.259935,"marketCap":3446553},{"date":"2025-01-10","current":-0.475065,"twenty":-2.863734,"median":-0.72665,"eighty":-0.259929,"marketCap":3238324},{"date":"2025-01-17","current":-0.474012,"twenty":-2.835741,"median":-0.71764,"eighty":-0.259929,"marketCap":3231144},{"date":"2025-01-24","current":-0.442411,"twenty":-2.819107,"median":-0.711202,"eighty":-0.259929,"marketCap":3015734},{"date":"2025-01-31","current":-0.344448,"twenty":-2.798015,"median":-0.677503,"eighty":-0.259929,"marketCap":2347964},{"date":"2025-02-07","current":-0.332512,"twenty":-2.77365,"median":-0.638737,"eighty":-0.259929,"marketCap":2266595},{"date":"2025-02-14","current":-0.283679,"twenty":-2.754191,"median":-0.610717,"eighty":-0.259929,"marketCap":2244871},{"date":"2025-02-21","current":-0.517141,"twenty":-2.731557,"median":-0.599865,"eighty":-0.259929,"marketCap":4092360},{"date":"2025-02-28","current":-0.446969,"twenty":-2.722753,"median":-0.585582,"eighty":-0.259929,"marketCap":3537054},{"date":"2025-03-07","current":-0.421035,"twenty":-2.689642,"median":-0.578624,"eighty":-0.259924,"marketCap":3331833},{"date":"2025-03-14","current":-0.410357,"twenty":-2.684528,"median":-0.570921,"eighty":-0.259924,"marketCap":3247330},{"date":"2025-03-21","current":-0.4279,"twenty":-2.684528,"median":-0.559538,"eighty":-0.259924,"marketCap":3386156},{"date":"2025-03-28","current":-0.402729,"twenty":-2.684528,"median":-0.554067,"eighty":-0.259924,"marketCap":3186971},{"date":"2025-04-04","current":-0.320353,"twenty":-2.684528,"median":-0.546694,"eighty":-0.259924,"marketCap":2535090},{"date":"2025-04-11","current":-0.38598,"twenty":-2.68367,"median":-0.542002,"eighty":-0.259929,"marketCap":3054422},{"date":"2025-04-17","current":-0.407153,"twenty":-2.68367,"median":-0.534539,"eighty":-0.259929,"marketCap":3221979},{"date":"2025-04-25","current":-0.454596,"twenty":-2.684528,"median":-0.52352,"eighty":-0.259924,"marketCap":3597414},{"date":"2025-05-02","current":-0.471376,"twenty":-2.684528,"median":-0.51915,"eighty":-0.259924,"marketCap":3730204},{"date":"2025-05-09","current":-0.350863,"twenty":-2.680238,"median":-0.507988,"eighty":-0.259924,"marketCap":2776527},{"date":"2025-05-16","current":-0.42774,"twenty":-2.657048,"median":-0.499292,"eighty":-0.259924,"marketCap":3555162},{"date":"2025-05-23","current":-0.399418,"twenty":-2.633216,"median":-0.48358,"eighty":-0.259924,"marketCap":3319761},{"date":"2025-05-30","current":-0.355845,"twenty":-2.617742,"median":-0.477172,"eighty":-0.259924,"marketCap":2957605},{"date":"2025-06-06","current":-0.458968,"twenty":-2.597957,"median":-0.474728,"eighty":-0.259924,"marketCap":3814707},{"date":"2025-06-13","current":-0.390704,"twenty":-2.586194,"median":-0.469198,"eighty":-0.259924,"marketCap":3247330},{"date":"2025-06-20","current":-0.36456,"twenty":-2.570487,"median":-0.459935,"eighty":-0.259826,"marketCap":3030036},{"date":"2025-06-27","current":-1.315292,"twenty":-2.513909,"median":-0.458589,"eighty":-0.259826,"marketCap":10932039},{"date":"2025-07-03","current":-1.106214,"twenty":-2.455304,"median":-0.458589,"eighty":-0.259826,"marketCap":9194287},{"date":"2025-07-11","current":-0.409585,"twenty":-2.388106,"median":-0.457929,"eighty":-0.259826,"marketCap":3404264},{"date":"2025-07-18","current":-0.382715,"twenty":-2.320796,"median":-0.455781,"eighty":-0.259826,"marketCap":3180935},{"date":"2025-07-25","current":-0.389251,"twenty":-2.277303,"median":-0.452546,"eighty":-0.259826,"marketCap":3235258},{"date":"2025-08-01","current":-0.35294,"twenty":-2.277303,"median":-0.449051,"eighty":-0.259826,"marketCap":2933461},{"date":"2025-08-08","current":-0.325344,"twenty":-2.246476,"median":-0.444518,"eighty":-0.259826,"marketCap":2704096},{"date":"2025-08-15","current":-0.339869,"twenty":-2.210424,"median":-0.441597,"eighty":-0.259826,"marketCap":2824815},{"date":"2025-08-22","current":-0.322439,"twenty":-2.17387,"median":-0.436715,"eighty":-0.259826,"marketCap":2679952},{"date":"2025-08-29","current":-0.525148,"twenty":-2.158445,"median":-0.436715,"eighty":-0.259826,"marketCap":4364765},{"date":"2025-09-05","current":-0.503468,"twenty":-2.159203,"median":-0.436091,"eighty":-0.259728,"marketCap":4184568},{"date":"2025-09-12","current":-0.52033,"twenty":-2.155257,"median":-0.436715,"eighty":-0.259826,"marketCap":4324721},{"date":"2025-09-19","current":-0.568509,"twenty":-2.122683,"median":-0.436715,"eighty":-0.259826,"marketCap":4725158},{"date":"2025-09-26","current":-0.636785,"twenty":-2.122683,"median":-0.436715,"eighty":-0.259826,"marketCap":5197525},{"date":"2025-10-03","current":-0.660153,"twenty":-2.122683,"median":-0.436715,"eighty":-0.259826,"marketCap":5388260},{"date":"2025-10-10","current":-0.686443,"twenty":-2.122683,"median":-0.436715,"eighty":-0.259826,"marketCap":5602837},{"date":"2025-10-17","current":-0.607575,"twenty":-2.11437,"median":-0.436715,"eighty":-0.259826,"marketCap":4959106},{"date":"2025-10-24","current":-0.59297,"twenty":-2.11437,"median":-0.436715,"eighty":-0.259826,"marketCap":4839897},{"date":"2025-10-31","current":-0.540391,"twenty":-2.11437,"median":-0.436715,"eighty":-0.259826,"marketCap":4410744},{"date":"2025-11-07","current":-0.498036,"twenty":-2.081116,"median":-0.436715,"eighty":-0.259826,"marketCap":4065037},{"date":"2025-11-14","current":-0.618131,"twenty":-2.036778,"median":-0.436715,"eighty":-0.259826,"marketCap":5075576},{"date":"2025-11-21","current":-0.602008,"twenty":-1.942639,"median":-0.436715,"eighty":-0.259826,"marketCap":4943186},{"date":"2025-11-28","current":-0.640536,"twenty":-1.841683,"median":-0.436715,"eighty":-0.259826,"marketCap":5259550},{"date":"2025-12-05","current":-0.645352,"twenty":-1.807487,"median":-0.436715,"eighty":-0.259826,"marketCap":5299095},{"date":"2025-12-12","current":-0.669433,"twenty":-1.788812,"median":-0.436715,"eighty":-0.259826,"marketCap":5496823},{"date":"2025-12-19","current":-0.621272,"twenty":-1.748866,"median":-0.436715,"eighty":-0.259826,"marketCap":5101368},{"date":"2025-12-26","current":-0.592376,"twenty":-1.712228,"median":-0.436715,"eighty":-0.259826,"marketCap":4864095},{"date":"2026-01-02","current":-0.510503,"twenty":-1.660934,"median":-0.436715,"eighty":-0.259826,"marketCap":4191821},{"date":"2026-01-09","current":-0.602008,"twenty":-1.636509,"median":-0.436715,"eighty":-0.259826,"marketCap":4943186},{"date":"2026-01-16","current":-0.515319,"twenty":-1.577888,"median":-0.436715,"eighty":-0.259826,"marketCap":4231367},{"date":"2026-01-23","current":-0.515319,"twenty":-1.543692,"median":-0.436715,"eighty":-0.259826,"marketCap":4231367},{"date":"2026-01-30","current":-0.515319,"twenty":-1.480186,"median":-0.436715,"eighty":-0.259826,"marketCap":4231367},{"date":"2026-02-06","current":-0.472745,"twenty":-1.441105,"median":-0.436715,"eighty":-0.259826,"marketCap":3881785},{"date":"2026-02-13","current":-0.472617,"twenty":-1.419122,"median":-0.436715,"eighty":-0.259826,"marketCap":3622305}],"updateTime":1771116857372},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610706942","title":"InMed Pharmaceuticals Inc. Q2 BayMedica revenue drops 26% to USD 0.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2610706942","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610706942?lang=en_us&edition=fundamental","pubTime":"2026-02-12 19:04","pubTimestamp":1770894246,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDLYYmmc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2610910964","title":"InMed Pharma Q4 R&D expenses USD 0.63 million, down 30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610910964","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610910964?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:05","pubTimestamp":1770847513,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. reported its results for the quarter ended December 31, 2025. For the Pharma segment, research and development expenses were USD 0.63 million for the quarter, marking a 30 percentage point decrease. General and administrative expenses totaled USD 1.32 million, a decrease of 3 percentage points. Amortization and depreciation expenses were USD 0.05 million, reflecting a 2 percentage point decrease. During the period, InMed advanced its INM-901 program, completing the first preclinical study with the oral formulation administered in large animals. These results will guide the design of a planned human Phase 1 clinical trial. The company also completed additional chemistry, manufacturing, and controls development to scale up the INM-901 manufacturing process in preparation for Investigational New Drug enabling studies and regulatory interactions with the FDA. Revenue for the company is derived from manufacturing and distribution sales of bulk rare cannabinoid pro","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nNDL8hWlBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2592947515","title":"InMed Pharmaceuticals Inc. Held Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2592947515","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592947515?lang=en_us&edition=fundamental","pubTime":"2025-12-18 09:01","pubTimestamp":1766019665,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. held its annual general and special meeting of shareholders on December 17, 2025. Shareholders approved the election of the board of directors and the appointment of CBIZ CPAs P.C. as auditors for the following year. Approval was also granted for the potential issuance of 20% or more of the company's common shares pursuant to the Standby Equity Purchase Agreement with YA II PN, Ltd.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile  on December 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL9J0pkw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2591647203","title":"ADVISORY-Dated alerts on InMed Pharmaceuticals withdrawn","url":"https://stock-news.laohu8.com/highlight/detail?id=2591647203","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591647203?lang=en_us&edition=fundamental","pubTime":"2025-12-15 23:05","pubTimestamp":1765811124,"startTime":"0","endTime":"0","summary":"ADVISORY-Dated alerts on InMed Pharmaceuticals withdrawnAlerts published on InMed Pharmaceuticals INM.O expecting the H.R. 5371 Act to have a negative impact on its unit Baymedica were dated and have ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0AQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2591480642","title":"InMed Pharmaceuticals Inc - Expects Negative Impact on Baymedica From New Act H.r. 5371 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2591480642","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591480642?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:37","pubTimestamp":1765809436,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nFWN3XL0AQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2591642942","title":"BayMedica Faces Uncertainty as New Law Threatens Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2591642942","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591642942?lang=en_us&edition=fundamental","pubTime":"2025-12-15 22:33","pubTimestamp":1765809187,"startTime":"0","endTime":"0","summary":"BayMedica, InMed Pharmaceuticals Subsidiary, Faces Material Impact from New Legislation. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL1VyMW8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2584814511","title":"Why Did Vivakor Shares Surge 17% After Hours?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584814511","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584814511?lang=en_us&edition=fundamental","pubTime":"2025-11-20 16:55","pubTimestamp":1763628900,"startTime":"0","endTime":"0","summary":"Vivakor shares jumped 17% in after-hours trading after the company reported widening losses and rising interest expenses.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/20/Market-Prudence-To-Increase-Amid-Growing.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/20/Market-Prudence-To-Increase-Amid-Growing.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/25/11/48969121/why-did-vivakor-shares-surge-17-after-hours","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48969121/why-did-vivakor-shares-surge-17-after-hours","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4120","VIVK","INM","BK4007","BK4144"],"gpt_icon":0},{"id":"2584183421","title":"What's Driving InMed's (INM) 22% After-Hours Surge?","url":"https://stock-news.laohu8.com/highlight/detail?id=2584183421","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584183421?lang=en_us&edition=fundamental","pubTime":"2025-11-20 15:28","pubTimestamp":1763623737,"startTime":"0","endTime":"0","summary":"InMed shares jumped 22% in after-hours trading after the company reported encouraging large-animal study results for its Alzheimer&#39;s drug candidate INM-901.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/25/11/48968515/whats-driving-inmeds-inm-22-after-hours-surge","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK4590","BK4144","INM","BK4007"],"gpt_icon":0},{"id":"2584979338","title":"InMed Pharmaceuticals Completes Key Study for INM-901","url":"https://stock-news.laohu8.com/highlight/detail?id=2584979338","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584979338?lang=en_us&edition=fundamental","pubTime":"2025-11-20 05:51","pubTimestamp":1763589103,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals ( ($INM) ) just unveiled an announcement. On November 18, 2025, InMed Pharmaceuticals announced the successful completion of ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inmed-pharmaceuticals-completes-key-study-for-inm-901?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inmed-pharmaceuticals-completes-key-study-for-inm-901?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2584893095","title":"InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901","url":"https://stock-news.laohu8.com/highlight/detail?id=2584893095","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584893095?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:14","pubTimestamp":1763471651,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals ( ($INM) ) has provided an update. InMed Pharmaceuticals announced the successful completion of pharmacokinetic studies for i...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inmed-completes-key-pharmacokinetic-studies-for-alzheimers-candidate-inm-901?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inmed-completes-key-pharmacokinetic-studies-for-alzheimers-candidate-inm-901?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2584932967","title":"InMed Pharmaceuticals Completes Large Animal Study for Alzheimer's Drug Candidate INM-901","url":"https://stock-news.laohu8.com/highlight/detail?id=2584932967","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584932967?lang=en_us&edition=fundamental","pubTime":"2025-11-18 20:31","pubTimestamp":1763469066,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. announced the successful completion of pharmacokinetic studies in large animal models for its Alzheimer's disease candidate, INM-901. The company reported that the oral formulation of INM-901 demonstrated a favorable bioavailability profile and achieved anticipated therapeutic levels of systemic exposure over a seven-day dosing period. Neurological assessments found no adverse neural or behavioral effects. These results, which have already been obtained, will support the design and planning of first-in-human clinical trials. InMed is preparing for a pre-IND meeting with the FDA and advancing further studies to support an IND submission.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL2hFfTp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2581445045","title":"InMed Pharmaceuticals reports $1.1 million in BayMedica revenues for Q1 fiscal 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2581445045","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581445045?lang=en_us&edition=fundamental","pubTime":"2025-11-07 05:51","pubTimestamp":1762465916,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. reported cash and cash equivalents of $9.3 million as of September 30, 2025, down from $11.1 million at the end of June 2025. Short-term investments were $42.9 thousand, and accounts receivable totaled $343.5 thousand. Inventories stood at $890.8 thousand. General and administrative expenses were $1.5 million for the three months ended September 30, 2025, and are expected to remain stable for the remainder of fiscal 2026. Research and development expenses decreased due to reduced spending on external contractors and compensation but are anticipated to increase as preclinical and IND-enabling work on lead program INM-901 advances. The company expects available cash to fund planned operations into the fourth quarter of calendar year 2026. Business developments include progress toward clinical readiness for INM-901, a small-molecule therapy targeting multiple pathways associated with Alzheimer's disease, and the addition of two new directors to the board.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL9qKrrK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2578652899","title":"InMed Pharmaceuticals Inc. Announces Date for Upcoming Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2578652899","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578652899?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:55","pubTimestamp":1761339326,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. has announced that it will hold its annual general and special meeting of shareholders virtually on December 17, 2025. Shareholders will have the opportunity to vote on key matters relating to the company. The management information circular with detailed information about the meeting and the matters to be addressed is available on the company's website, as well as through regulatory filings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 24, 2025, and is solely responsible for th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDL8pR5Ng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2578547730","title":"InMed Pharmaceuticals Files Amendment to Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2578547730","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578547730?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:06","pubTimestamp":1761336368,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. has filed an amendment to its annual report on Form 10-K/A for the fiscal year ended June 30, 2025. The amendment includes information previously omitted from the original filing, specifically Items 10, 11, 12, 13, and 14 of Part III of Form 10-K, as the company will not file a definitive proxy statement within the required timeframe. Additionally, new certifications from the principal executive officer and principal financial officer have been filed as exhibits. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDL94bp2w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2577587295","title":"InMed Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director John Steven Bathery","url":"https://stock-news.laohu8.com/highlight/detail?id=2577587295","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577587295?lang=en_us&edition=fundamental","pubTime":"2025-10-24 07:32","pubTimestamp":1761262320,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing names John Steven Bathery as a director and the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 23, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nNDL7V4pKc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2576093471","title":"InMed Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director Neil Klompas","url":"https://stock-news.laohu8.com/highlight/detail?id=2576093471","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576093471?lang=en_us&edition=fundamental","pubTime":"2025-10-18 08:34","pubTimestamp":1760747661,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Neil A. Klompas as a Director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 17, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251018:nNDL58XHnG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2575874646","title":"InMed Pharmaceuticals Appoints John Bathery to Board of Directors; Bryan Baldasare to Step Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2575874646","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575874646?lang=en_us&edition=fundamental","pubTime":"2025-10-16 20:31","pubTimestamp":1760617875,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. has appointed John Bathery to its Board of Directors, effective immediately. Bathery brings over 30 years of experience in the pharmaceutical industry, including leadership in global business development and corporate partnerships. The company also announced that Bryan Baldasare will not stand for re-election at the upcoming Annual General Meeting in December 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile  on October 16, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nNDL1wKtpy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","BK4007"],"gpt_icon":0},{"id":"2575295519","title":"InMed Pharmaceuticals Appoints Neil Klompas to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2575295519","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575295519?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:01","pubTimestamp":1760436093,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. has announced the appointment of Neil Klompas, CPA, CA, to its Board of Directors. Klompas brings over 30 years of experience in healthcare and biotechnology, including key leadership roles at Zymeworks Inc. He currently serves as CEO of Augerex Life Science Corp and holds board positions at NervGen Pharma and HTuO Biosciences.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL4KNXB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INM","ZYME","BK4139","BK4007"],"gpt_icon":0},{"id":"2569790783","title":"InMed Pharmaceuticals Reports Fiscal 2025 Results: Sales Increase 8% to $4.9M, Net Loss Widens to $8.2M","url":"https://stock-news.laohu8.com/highlight/detail?id=2569790783","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569790783?lang=en_us&edition=fundamental","pubTime":"2025-09-23 20:31","pubTimestamp":1758630671,"startTime":"0","endTime":"0","summary":"InMed Pharmaceuticals Inc. has announced its financial results for the fiscal year ending June 30, 2025. The company reported sales of $4.9 million in its BayMedica segment, marking an increase of $0.34 million, or 8%, compared to the previous year. The net loss for the company was recorded at $8.2 million, compared to a net loss of $7.7 million for the previous fiscal year. Research and development expenses decreased to $2.9 million from $3.2 million in the previous year, while general and administrative expenses increased to $6.6 million from $5.8 million. The company maintains a cash position of $11.1 million, which it expects will support its pharmaceutical developments into the fourth quarter of calendar year 2026. Additionally, InMed continued to advance its pharmaceutical pipeline, particularly with the INM-901 program, which targets multiple biological pathways related to Alzheimer's disease. The company also reported progress in the development of INM-089 for the treatment of ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDLb2D81r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INM"],"gpt_icon":0},{"id":"2569790207","title":"InMed Pharmaceuticals FY Net Income USD -8.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2569790207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569790207?lang=en_us&edition=fundamental","pubTime":"2025-09-23 20:30","pubTimestamp":1758630623,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nPLX330770:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","INM"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}